Strata Critical Medical, Inc.
SRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $248,693 | $225,180 | $146,120 | $50,526 |
| % Growth | 10.4% | 54.1% | 189.2% | – |
| Cost of Goods Sold | $189,774 | $183,058 | $123,845 | $40,008 |
| Gross Profit | $58,919 | $42,122 | $22,275 | $10,518 |
| % Margin | 23.7% | 18.7% | 15.2% | 20.8% |
| R&D Expenses | $3,184 | $4,627 | $5,545 | $1,684 |
| G&A Expenses | $81,711 | $95,174 | $62,510 | $30,142 |
| SG&A Expenses | $89,661 | $105,612 | $70,259 | $32,927 |
| Sales & Mktg Exp. | $7,950 | $10,438 | $7,749 | $2,785 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $92,845 | $110,239 | $75,804 | $34,611 |
| Operating Income | -$33,926 | -$68,117 | -$53,529 | -$24,093 |
| % Margin | -13.6% | -30.3% | -36.6% | -47.7% |
| Other Income/Exp. Net | $6,364 | $10,575 | $25,497 | -$19,602 |
| Pre-Tax Income | -$27,562 | -$57,542 | -$28,032 | -$43,695 |
| Tax Expense | -$255 | -$1,466 | -$772 | -$3,643 |
| Net Income | -$27,307 | -$56,076 | -$27,260 | -$40,052 |
| % Margin | -11% | -24.9% | -18.7% | -79.3% |
| EPS | -0.35 | -0.76 | -0.38 | -0.57 |
| % Growth | 53.9% | -100% | 33.3% | – |
| EPS Diluted | -0.35 | -0.76 | -0.38 | -0.57 |
| Weighted Avg Shares Out | 77,499 | 73,524 | 71,238 | 70,096 |
| Weighted Avg Shares Out Dil | 77,499 | 73,524 | 71,238 | 70,096 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7,214 | $8,442 | $3,434 | $460 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5,962 | $7,111 | -$16,338 | $596 |
| EBITDA | -$27,964 | -$61,006 | -$69,867 | -$23,497 |
| % Margin | -11.2% | -27.1% | -47.8% | -46.5% |